Survival of trophoblast cells in the low oxygen environment of human placentation requires metalloproteinase-mediated shedding of HBEGF and downstream signaling. A matrix metalloproteinase (MMP) antibody array and quantitative RT-PCR revealed upregulation of MMP2 post-transcriptionally in human first trimester HTR-8/SVneo trophoblast cells and placental villous explants exposed to 2% O 2 . Specific MMP inhibitors established the requirement for MMP2 in HBEGF shedding and upregulation. Because α-amanitin inhibited the upregulation of HBEGF, differentially expressed genes were identified by next-generation sequencing of RNA from trophoblast cells cultured at 2% O 2 for 0, 1, 2 and 4 h. Nine genes, all containing HIF-response elements, were upregulated at 1 h, but only HSPA6 (HSP70B') remained elevated at 2-4 h. The HSP70 chaperone inhibitor VER 155008 blocked upregulation of both MMP2 and HBEGF at 2% O 2 , and increased apoptosis. However, both HBEGF upregulation and apoptosis were rescued by exogenous MMP2. Proximity ligation assays demonstrated interactions between HSP70 and MMP2, and between MMP2 and HBEGF, supporting the concept that MMP2-mediated shedding of HBEGF, initiated by HSP70, contributes to trophoblast survival at the low O 2 concentrations encountered during the first trimester, and is essential for successful pregnancy outcomes. Trophoblast survival during human placentation, when oxygenation is minimal, required HSP70 activity, which mediated MMP2 accumulation and the transactivation of anti-apoptotic ERBB signaling by HBEGF shedding. Cell Death and Differentiation (2017) 24, 1772-1783; doi:10.1038/cdd.2017.104; published online 21 July 2017
In humans, the placenta is not fully perfused with oxygenated maternal blood until after the tenth week of pregnancy, rendering the implantation site a low (~2%) O 2 environment. 1 Atypical of most cells, human trophoblast (TB) cells survive at low O 2 , and proliferate more rapidly. 2 The epidermal growth factor (EGF) family member, heparinbinding EGF-like growth factor (HBEGF), which is highly expressed in the uteroplacental compartment during implantation and placentation, 3 prevents death of human TB cells exposed to low O 2 concentrations. 2 Although HBEGF is upregulated~100-fold in TB cells after exposure to 2% O 2 , HBEGF mRNA remains unchanged (2500 copies/cell). 2 As O 2 increases upon full perfusion of the intravillous space after 10 weeks of gestation, 1 HBEGF positively regulates TB motility and invasion. 3 Survival of TB cells at low (2%) O 2 requires metalloproteinase-mediated shedding of membranebound proHBEGF and HBEGF downstream signaling. 2 HBEGF secretion allows activation of ERBB receptor tyrosine kinases, including its cognate receptors, EGF receptor/ ERBB1 and ERBB4. 3 During hypoxia, HBEGF is upregulated through an autocrine feedback mechanism that blocks apoptosis through parallel signaling. 2, 3 HBEGF activation of ERBB receptor tyrosine kinases prevents apoptosis by activating p38 (MAPK14), while biosynthesis of HBEGF is mediated by any one of the MAPKs, p38, ERK (MAPK1/3) or JNK (MAPK8/9/10), based on experiments using specific inhibitors. 3, 4 However, it is unclear whether the MAPKs specifically function downstream of HBEGF, or also operate further upstream in the cascade initiated by hypoxia before proHBEGF shedding. The hypertensive pregnancy disorder, preeclampsia, in which TB invasion is reduced and apoptosis elevated, is characterized by dysregulation of HBEGF and other components of the EGF signaling system. 5, 6 Therefore, HBEGF deficiency could contribute to TB dysfunction associated with placental insufficiency disorders.
It is well established that metalloproteinases contribute to invasion and tissue remodeling. 7, 8 Implantation and TB invasion are closely linked to expression of matrix metalloproteinases (MMPs). 9 The gelatinases (gelatinase A/MMP2; 72-kDa, and gelatinase B/MMP9; 92-kDa), which target major components of basement membranes (e.g., collagen IV), are expressed by TB cells and key to the invasion process. signaling molecules. 7, 11 Cheng et al. reported that bradykinininduced proliferation of rabbit corneal cells is blocked by an inhibitor of both MMP2 and MMP9, as well as an inhibitor of HBEGF, suggesting that an MMP could contribute to the cleavage of proHBEGF.
12 MMP2 participates in a proteolytic cascade in αT3-1 cells that directs both proHBEGF shedding and EGFR transactivation. 13 In addition, its rapid release in CMTC9 cells after E2 stimulation is correlated with cleavage of proHBEGF. 14 We previously found that treatment with a general metalloproteinase inhibitor blocks HBEGF accumulation in human TB cells at low O 2 , causing apoptosis that is rescued with recombinant HBEGF, but not other EGF-like ligands. 2 Autocrine HBEGF activity in TB cells requires, in addition to metalloproteinase-mediated shedding of HBEGF, binding to either EGFR or ERBB4. Blocking HBEGF signaling prevents its upregulation at 2% O 2 , suggesting that low levels of resident proHBEGF are cleaved through activation of metalloproteinases to initiate its autocrine accumulation. 2 Human TB survival at low O 2 is independent of invasion, but equally important for normal placentation. To understand the molecular mechanism of TB survival at low O 2 , the HTR-8/ SVneo human TB cell line 15 was used. HTR-8/SVneo is an immortalized cell line established from human first trimester cytotrophoblast cells. 15 HTR-8/SVneo cells express the TB epithelial marker cytokeratin (KRT7), as well as the beta subunit of human chorionic gonadotropin (β-hCG), which is TB-specific. 16 This cell line possesses the ability to invade Matrigel basement membrane without tumorigenicity, and expresses the TB-specific major histocompatibility protein, HLA-G, when induced by Matrigel to differentiate. 16 In response to Matrigel, HTR-8/SVneo cells switch integrin expression 3 in association with invasive differentiation, while in response to hypoxia, proliferation increases and extravillous differentiation is inhibited. 16 To examine the hypothesis that MMPs contribute to the shedding and upregulation of HBEGF required for TB survival at the low O 2 concentrations encountered in the first trimester, we used HTR-8/SVneo human TB cells, and conducted confirmatory experiments with human first trimester villous explants.
17,18

Results
Upregulation of MMP2 at low O 2 . Using a human MMP antibody array, we observed that relative expression of MMP2, but not MMP9 or other MMPs, increased 1.7-fold in HTR-8/SVneo TB cells cultured for 4 h at 2% O 2 (Figure 1a ), compared with TB cells cultured at 20% O 2 . The specific increase in expression of MMP2, and not MMP9, was confirmed by western blotting (Figure 1b ). Comparison to recombinant MMP2 and MMP9 zymogens indicated that MMP2 in TB lysates was active, based on its lower molecular weight. Cellular MMP2 was quantified temporally by ELISA after shifting TB cells to 2% O 2 . The MMP2 concentration abruptly increased 164-fold (Po0.0001) after 2 h at 2% O 2 (Figure 1c ), which is 2 h before HBEGF upregulation.
2 MMP2 expression was homogenous throughout the TB cell culture at 2% O 2 , similar to HBEGF expression (Supplementary Figure 1B) .
Role of MMP2 in HBEGF upregulation. To determine whether MMP2 has a functional role in HBEGF regulation by O 2 , specific inhibitors of MMP2 and MMP9 were supplemented in culture medium during manipulation of O 2 . HBEGF failed to accumulate in TB cells cultured at 2% O 2 for 4 h when MMP2 was inhibited (Figure 1d ). However, MMP9 inhibition had no effect on HBEGF accumulation at low O 2 . A third inhibitor that targets both MMP2 and MMP9 also inhibited HBEGF accumulation. Additionally, terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) showed increased (Po0.0001) TB cell death when both MMP2 and MMP9, or only MMP2, were inhibited (Figure 1e ), while MMP9 inhibition produced no apoptosis at low O 2 . We conclude that MMP2, but not MMP9, either directly or indirectly mediates the proteolytic cleavage of proHBEGF, and subsequent survival signaling.
Role of MAPKs in MMP2 upregulation. We previously showed that upregulation of HBEGF at low O 2 requires MAPK signaling. 4 MMP2 was quantified by ELISA in extracts of TB cells cultured at 2% O 2 for 4 h, with or without specific inhibitors of ERK, p38 and JNK, or the corresponding inactive structural analogs ( Table 1 ). Inhibitors of MAPKs had no effect on the increased MMP2 expression at 2% O 2 .
MMP2 mRNA expression. To determine whether MMP2 is transcriptionally upregulated at low O 2 , its expression was quantified by qPCR, using RNA extracted from HTR-8/SVneo cells cultured at 20% and 2% O 2 for 1-4 h. Expression values, normalized to GAPDH, were calculated for both MMP2 (Figure 2a ) and HBEGF (Figure 2b ). MMP2 mRNA, like HBEGF message, did not change (P = 0.8) at 2% O 2 , suggesting that their proteins are both regulated post-transcriptionally.
Role of transcription in HBEGF upregulation. TB cells were cultured at 2% O 2 with or without α-amanitin, an inhibitor of RNA polymerase-II, 19 to examine the role of de novo transcription in the upregulation of HBEGF. Cells were preincubated with α-amanitin for 3 h to allow complete inhibition of transcription before exposure to 2% O 2 . Elevation of HBEGF protein after culture at 2% O 2 for 6 h was abrogated in a dose-dependent manner by α-amanitin, with maximal inhibition attained at 5 μg/ml (Figure 2c ). ELISA demonstrated that addition of rMMP2 increased (Po0.0001) HBEGF at 20% O 2 to the same extent as TB culture at 2% O 2 ( Figure 2d) . Furthermore, addition of rMMP2 rescued (Po0.0001) HBEGF biosynthesis in the presence of α-amanitin at 2% O 2 (Figure 2d ), suggesting that MMP2 accumulates due to hypoxia-induced transcription. It also demonstrates that sufficient amounts of HBEGF mRNA remain after α-amanitin treatment for biosynthesis of HBEGF.
Identification of differentially expressed transcripts.
Transcripts differentially expressed in TB cells at the two O 2 concentrations were identified, using a non-biased transcriptomics approach. RNA-seq analysis revealed a total of 9 upregulated ( (Figure 3a ). We focused on upregulated genes, based on the effects of α-amanitin inhibition at 2% O 2 . HSPA6 was most upregulated (870-fold) ( Table 2) , and the only gene that remained elevated at 2-4 h (Figures 3b and c) . Elevated HSPA6 expression at 2% O 2 was validated using qPCR (18-fold, Po0.0001) and western blotting (2.3 fold, Po0.05) (Figures 3d and e) . Additionally, the homogenous increase in expression of HSPA6 at 2% O 2 was validated in the HTR-8/ SVneo cell line (Supplementary Figure 1B) . Extraction of the promoter region revealed two overlapping hypoxia response elements (HREs) 2.4 kb upstream of the 5′-most HSPA6 transcriptional start site (Supplementary Figure 2) . (Figure 5d ). Regulation of MMP2 in placental explants. Using immunocytochemistry and ELISA, we confirmed the observed increase in MMP2, using first trimester villous explants cultured at 8% or 2% O 2 (Figures 7a and b) . Furthermore, it was confirmed that HSP70 inhibitor prevents the upregulation of MMP2 (Figures 7a and b) and HBEGF (Figures 7c and d) . Both MMP2 and HBEGF were most prominently expressed in the TB. rMMP2 increased (Po0.0001) HBEGF at 8% O 2 , and rescued (Po0.0001) HBEGF upregulation at 2% O 2 during treatment with HSP70 inhibitor (Figures 7c and d) . TUNEL showed increased (Po0.05) cell death during HSP70 inhibition at 2% O 2 that was rescued (Po0.05) by rMMP2 (Figures 7e and f) , suggesting that survival at 2% O 2 requires HSPA6 activity.
Interaction of key regulators of survival signaling. Our findings suggest that HSPA6, MMP2 and HBEGF interact to initiate HBEGF upregulation and inhibition of apoptosis in TB cells exposed to 2% O 2 . Proximity ligation assays (PLA) were used to determine whether these proteins physically interact at 2% O 2 . Examining confluent fields of TB cells (Figures  8a-d , upper panels, DAPI) interactions were identified between HSPA6 and MMP2, MMP2 and HBEGF, but not between HSPA6 and HBEGF, or control cells treated with non-immune primary antibody (Figures 8a-d , lower panels, red PLA signal). These results confirm our experimental findings that HSPA6 mediates upregulation of MMP2, and suggest a direct interaction. Furthermore, PLA results indicated that MMP2 could be the sheddase for HBEGF. Based on these findings, a mechanism is proposed for HBEGF shedding in response to low O 2 ( Figure 9 ).
Discussion
The regulation of HBEGF signaling during implantation and placentation is critical for TB survival and invasion. 3 An autocrine, post-transcriptional mechanism induced at low O 2 upregulates HBEGF synthesis and secretion, providing an important survival factor during early gestation. 2, 3 Evidence suggests that autocrine signaling is initiated by metalloproteinase-mediated shedding of proHBEGF. 2 In seeking a metalloproteinase responsible for HBEGF shedding, a human MMP antibody array, verified by western blot and ELISA, implicated proteolysis by MMP2. A functional role for MMP2 in the accumulation of HBEGF and cell survival was established using a specific inhibitor. However, MMP2 mRNA concentration was unaltered by reduced O 2 , suggesting that it was regulated post-transcriptionally. Interestingly, very low O 2 (0.1%) increases MMP2 mRNA levels 1.7-fold in TB cells isolated from first trimester placentas, 23 which was not found in our study. However, culture at 2% O 2 could differ significantly from 0.1% O 2 , and account for the different outcomes. Transcriptomic analysis identified HSPA6, a member of the HSP70 family, as a potential regulator upstream of MMP2. Using an inhibitor of HSP70 and exogenous rMMP2, evidence was obtained supporting a mechanism wherein low O 2 concentrations encountered by TB cells during the first 10 weeks of placentation induce transcription of HSP70, a chaperone that directly or indirectly facilitates MMP2 accumulation, likely through physical interaction (Figure 8b) . MMP2, in turn, mediates HBEGF shedding. 7, 13 It remains uncertain whether other metalloproteinases that activate the HBEGF sheddase are co-regulated with MMP2. However, PLA suggested that MMP2 and HBEGF interact (Figure 8d) , supporting a role for MMP2 as the HBEGF sheddase. The secretion of HBEGF initiates autocrine signaling through its cognate receptors, EGFR and ERBB4, mobilizing biosynthesis from constitutively expressed, but latent, HBEGF mRNA ( Figure 9 ). We recently proposed that HBEGF signaling activates translation from HBEGF mRNA through interactions of microRNA with its 3′ untranslated region. 24 HBEGF regulates TB survival and invasion, two crucial functions that are compromised in pregnancies complicated by preeclampsia. 25, 26 Supplementation with HBEGF and other EGF family members, including EGF or TGFα, has little effect on proliferation, but is highly effective at converting TB cells to an invasive phenotype. 3 The extensive expression of HBEGF by TB cells, particularly within extravillous populations, 5 could be vital for their invasive activities during the establishment of pregnancy and physiological conversion of spiral arteries. Accordingly, HBEGF and other components of the EGF signaling system are disrupted in placentas of women with preeclampsia. 5, 6 The increased oxidative damage to TB cells 27 and the decrease in HBEGF in preeclamptic placentas is consistent with the hypothesis that HBEGF is an important survival factor throughout gestation.
Jessmon et al. showed that HBEGF activates ERK, p38 and JNK in human TB cells, while treatment with specific inhibitors indicated that hypoxia upregulates HBEGF biosynthesis through any one of the three examined MAPKs. 2, 3 However, it was unclear whether this MAPK pathway was functional upstream or downstream of HBEGF shedding. Therefore, MMP2 was quantified in human TB cells cultured at 2% O 2 with specific inhibitors of ERK, p38 and JNK. These inhibitors did not influence the upregulation of MMP2 at low O 2 , suggesting that the MAPKs function exclusively downstream of HBEGF signaling through the ERBB1/4 tyrosine kinases in human TB cells, as indicated in Figure 9 .
Although both MMP2 and HBEGF are regulated by O 2 posttranscriptionally, HBEGF upregulation by low O 2 or CoCl 2 was blocked by α-amanitin, suggesting the requirement for transcription of other genes that regulate HBEGF. The transcriptome was analyzed as TB were exposed to 2% O 2 , which revealed HSPA6/HSP70B′ as the most highly upregulated gene at 1-4 h. Extraction of the HSPA6 promoter revealed two overlapping HREs on the sense and anti-sense strands. HREs also appeared in the promoters of eight other mRNAs that increased 1 h after exposure to low O 2 . The presence of HREs in all upregulated genes suggested a potential role for HIFs. HIF proteins are stabilized at low O 2 , 28 and activate transcription of targeted genes by interaction with specific HREs in the gene promoters, 29 along with transcriptional coactivators, to form an initiation complex. 30 We suspected that either HIF1A or HIF2A could be involved in the response of TB cells to low O 2 , based on their accumulation under the influence of CoCl 2 or 2% O 2 , which was previously reported in JEG3 choriocarcinoma cells. 31 Knockdown of HIF1A and HIF2A was without effect, which suggested that HIF's are not essential for the upregulation of HBEGF. However, residual levels of HIFs might have been adequate to maintain function. An inhibitor of HIFs is not currently available.
Induction of heat shock proteins (HSPs) in response to cellular stress has been proposed as a potential strategy of eukaryotic cells to combat lethal conditions. 32 Within the HSP family, HSP70 functions in the recovery of cells from stress, and in guarding against further insults.
33 HSP70 is a multigene family that includes the stress-inducible members HSPA6 and HSPA1A/HSP70-1.
22,34 HSP70 forms a molecular chaperone complex with HSP90, another highly conserved and essential HSP family member. 35, 36 This molecular chaperone complex is dependent on the hydrolysis of ATP, and ADP/ATP exchange, and is mediated by association with HOP (Hsp70/ Hsp90-organizing protein)/STIP1 (stress-induced phosphoprotein 1). 37 The HSP70/HSP90 molecular chaperone complex, optimized by HOP, coordinates interactions that ensure folding and conformational regulation of proteins under stress. 38, 39 RNAi knockdown of HOP in pancreatic cancer cells decreases MMP2 expression. 40 Additionally, inhibition or depletion of HSP70 in the breast cancer cell line, MA-MB-231, decreases cell migration and invasion due to a lack of MMP2 activation. 41 This suggests that molecular relationships Figure 9 Proposed mechanism for regulation of HBEGF by O 2 . Low (2%) O 2 upregulates HSP70 (1). HSP70 interacts with MMP2 (2) and regulates the accumulation of activated MMP2 at the cell surface (3), where it interacts with proHBEGF (4) possibly as its sheddase. The released sHBEGF binds (5) to its receptors, ERBB1 and ERBB4, through its EGF-like domain, and to heparan sulfate proteoglycans (HSPG) through its heparin-binding domain. ERBB downstream signaling activates MAPKs (6) required for biosynthesis of proHBEGF from the pool of HBEGF mRNA (7) . HBEGF autocrine signaling thereby increases HBEGF secretion to achieve extracellular HBEGF concentrations (41 nM) sufficient to inhibit apoptosis at 2% O 2 . Red arrows indicated that a direct interaction was demonstrated using proximity ligation assays between HSPs, various signaling proteins, and partner proteins mediate the integrity of signal transduction pathways. 42 Our findings further support the role for HSP70 in mediating MMP2 function through direct interaction.
The signaling cascade delineated in the present study ( Figure 9 ) could influence multiple physiological processes that have a key role in placentation. MMP2 belongs to a family of extracellular matrix-remodeling enzymes that have been implicated in the regulation of vasculogenesis, which is disrupted in placental insufficiency disorders, including preeclampsia. There is compelling evidence that MMP2, but not MMP9, increases in women who subsequently develop preeclampsia. [43] [44] [45] [46] HSP70 also appears to be altered in adverse pregnancies. In a pilot study, higher levels of HSP70 were reported in patients with early onset of severe PE. 47, 48 Fukushima et al. reported that serum levels of HSP70 are constant throughout normal pregnancy, but increase significantly in women with preeclampsia or preterm delivery. 49 Increased circulating HSP70 in preeclamptic patients could arise from systemic inflammation caused by disease and oxidative stress. 50, 51 In term preeclamptic placentas, HIF1A and HSP70 are both elevated and localize prominently in syncytiotrophoblasts and villous endothelial cells. 31 In another study of HSP70 in term placentas, both mRNA and protein increased in women with preeclampsia and intrauterine growth restriction. 52 However, there has been no information reported on the expression or role of placental HSP70 in the first trimester before this study.
Using a human TB cell line and a villous explant model, we have established a role for HSPA6 (HSP70B′) in the regulation of MMP2 biosynthesis, which is required for HBEGF shedding at low O 2 . These findings suggest that TB survival in the low O 2 environment during early pregnancy requires this signaling pathway. Disruption of any component during the first trimester could compromise TB survival and function, leading to placental insufficiency and the resulting obstetrical complications of pregnancy.
Materials and Methods
Cell culture and treatments. The first trimester human TB cell line, HTR-8/ SVneo, 15 were grown in either 96-well culture plates (~500 000 cells) or T25 tissue culture flasks (~85% confluency) and cultured during experiments in sterile DMEM/ F-12 with 1 mg/ml BSA at either 20% O 2 or 2% O 2 . Cells were treated by adding to the culture medium 1-10 μg/ml α-amanitin (Sigma-Aldrich, St. Louis, USA) (3 h pretreatment with α-amanitin), 250 μM CoCl 2 (Sigma-Aldrich), inhibitors (EDM Chemicals, Inc., Gibbstown, NJ, USA) specific for MMP2 and MMP9 ((2R)-[(4-Biphenylylsulfonyl)amino]-N-hydroxy-3-phenylpropionamide, BiPS; 100 nM), 53 MMP2 only ((2-((isopropoxy)-(1,1′-biphenyl-4-ylsulfonyl)-amino) )-N-hydroxyacetamide; 250 nM) 54 or MMP9 only (MMP9 Inhibitor I; 100 nM), 55 specific inhibitors for ERK, JNK, and p38, 4 HSP70 inhibitor (VER 155008, Santa-Cruz Biotech, Dallas, TX, USA; 0.05-100 μM), and 10 nM recombinant MMP2 (R&D Systems, Minneapolis, MN, USA; rMMP2). For protein analysis attached cells were extracted using cell lysis buffer (Cell Signaling, Beverly, MA, USA) and total cellular protein concentrations were determined using Pierce BCA protein assay kit (ThermoFisher Scientific, Waltham, MA, USA). The HTR-8/SVneo cell line was maintained in DMEM/F-12 with 10% donor calf serum at 20% O 2 between passages 30-50, and routinely checked for homogeneous production of β-hCG, KRT7, and when cultured on Matrigel, HLA-G. Serum was replaced with BSA beginning 24 h before all experiments.
Villous explant culture. Placental tissues were obtained with Wayne State University Institutional Review Board approval and patient informed consent from first trimester terminations at a Michigan family planning facility. Fresh tissue was placed on ice in PBS and immediately transported to the laboratory. The chorionic villi were dissected into pieces of~5 mg wet weight and transferred individually into DMEM/F-12 culture medium supplemented with 10% donor calf serum, 100 I.U. penicillin and 100 μg/ml streptomycin in a 24-well culture plate (Costar, Corning, NY, USA) for villous explant culture. 56 Treatments were performed as described for the cell line.
Antibody arrays. Cell lysates (1 ml) were incubated overnight with antibody array membranes, using a human MMP antibody array kit (Abcam, Cambridge, MA, USA). The membranes were washed and incubated with a secondary biotinconjugated antibody, followed by incubation with horseradish peroxidaseconjugated streptavidin, according to the manufacturer's direction. The arrays were developed, using enhanced chemiluminescence, and imaged on the ChemiDoc Imaging System (BioRad, Hercules, CA, USA). Labeling of each protein in the array was quantified using ImageJ software (NIH-http://rsbweb.nih.gov/ij/). The mean of six negative controls was subtracted for background correction, and the mean of six positive controls was used to normalize the data and calculate the relative expression levels.
Western blotting. Western blots were performed as previously described. 16 Briefly, cellular lysates, or recombinant proMMP2 or proMMP9 (R&D Systems), were diluted in SDS sample buffer containing 5% β-mercaptoethanol, run on precast 4%-20% Tris-HCl gradient gels (BioRad), and blotted with antibodies against MMP2, MMP9, HIF1A (R&D Systems), HIF2A/EPAS1 (Novus Biologicals, Littleton, CO, USA), β-actin (Cell Signaling) and HSPA6 (Abcam) diluted 1 : 1000 in TTBS and 5% milk. Densitometry was used to quantify gray levels of protein bands of interest, using image analysis software (SimplePCI, Hamamatsu). Background gray levels, determined in a blank lane, were subtracted to obtain the specific gray level for each band. Values for proteins of interest were divided by values for the loading controls (β-actin) before comparison.
ELISA. Cells were cultured and treated in six-well plates. ELISA was conducted in duplicate, using HBEGF, MMP2, HIF1A and HIF2A DuoSet ELISA Development kits (R&D Systems). The optical density of the final reaction product was determined at 450 nm using a programmable multiplate spectrophotometer (Power Wave Workstation; Bio-Tek Instruments, Winooski, VT, USA) with automatic wavelength correction. Data are presented as nanograms (ng) of HBEGF HIF1A, HIF2A, or MMP2 per microgram (μg) of total protein, determined using standard curves generated with the respective recombinant proteins (R&D Systems).
Immunocytochemistry. Immunohistochemistry was performed using a DAKO (Carpinteria, CA, USA) Autostainer Universal Staining System, as previously described. 56 Rehydrated sections of cultured explants were labeled for 1 h at 25°C with 5 μg/ml goat polyclonal antibody against MMP2 and human recombinant HBEGF (R&D Systems) that recognizes both membrane and secreted forms of the protein and 2.5 μg/ml antibody against cytokeratin (CK7) specific for TB and counterstained with hematoxylin. Controls were incubated with 10 μg/ml nonimmune goat IgG (Jackson Immunoresearch Laboratories, West Grove, PA, USA). Tissues were then incubated 1 h at 25°C with 0.1 μg/ml rabbit anti-goat IgG (Jackson Immunoresearch). Slides were viewed at 400 × magnification using a Leica (Wetzlar, Germany) DM IRB inverted microscope and imaged with spot camera.
HTR-8/SVneo cells cultured in 96-well plates were labeled with monoclonal antibodies against HBEGF (R&D Systems) diluted 1 : 500, MMP2 (R&D Systems) diluted 1 : 200, HSPA1A (Abcam) diluted 1 : 400, or HSPA6 (Abcam) diluted 1 : 400, HIF1A and HIF2A (R&D Systems) diluted 1: 200. To visualize and quantify bound primary antibody, an Envision System peroxidase anti-mouse/rabbit kit (DAKO) was used. Staining (gray level) was imaged using a Leica DM IRB epifluorescence microscope, and images were captured using a Hamamatsu Orca digital camera, or a Spot Jr. (Diagnostic Instrument Inc., Sterling Heights, MI, USA) color digital camera. Images were semi-quantified from triplicate wells in each experiment using SimplePCI (Hamamatsu) imaging software, as previously described. 56 TUNEL. Cell death based on DNA fragmentation was quantified using the TUNEL method. Cells or tissue sections prepared for immunohistochemistry were assayed using a fluorescein-based cell death detection kit (Roche Applied Science, Indianapolis, IN, USA) according to the manufacturer's instructions. Images were captured from triplicate wells in each experiment, as described for immunocytochemistry.
qPCR. RNA from HTR-8/SVneo cells was collected using the miRNeasy kit (Qiagen, Germantown, MD, USA), according to the manufacturer's protocol. RNA concentration was determined using the NanoDrop spectrophotometer and purity was ascertained with a microfluidic Bioanalyzer (Agilent Technologies-2100 Electrophoresis Bioanalyzer Instrument). RNA was used in subsequent qPCR 57 analysis. Reverse transcription was performed using the Quantitect Reverse Transcription kit (Qiagen), and qPCR for MMP2, HBEGF and HSPA6 was conducted in triplicate with the Quantitect SYBR Green PCR kit without UNG (Qiagen), in a final volume of 25 μl. GAPDH and SDHA were used as housekeeping gene to normalize the data. Semi-quantiative analysis was performed according to the ΔΔCt method. 58 Primers for GAPDH, SDHA, HBEGF, MMP2 and HSPA6 were obtained from Qiagen.
Proximity ligation assay. PLA was performed in situ using Duolink In Situ Red Starter Kit Mouse/Rabbit kit (Sigma-Aldrich) according the manufacturer instruction. Briefly, following the treatment, HTR-8/SVneo cells were fixed, permeabilized and dual labeled with primary antibodies for HSPA6 and MMP2, HSPA6 and HBEGF, MMP2 and HBEGF in pre-blocking buffer (0.05% Triton X-100 in PBS, pH 7.4) overnight at 4°C. A negative control was also included in this experiment by incubating the cells in blocking solution without primary antibodies. Next, cells were washed and incubated with rabbit plus and mouse minus PLA probes for 60 min at 37°C. After a brief wash, the ligation ligase mixture was added and cells were incubated for another 30 min at 37°C followed by an amplification step where adding the amplification-polymerase solution generates a rolling DNA circle. Hoechst 33342 was used to stain nuclei. The fluorescently labeled oligonucleotides were visualized by a Nikon Eclipse 90i epifluorescence microscope (Nikon Inc., Melville, USA).
HIF1A and HIF2A knockdown. HTR-8/SVneo cells were transfected in a 6-well plate (110 000 per well) for 48 h with four siRNAs that target bothe HIF1A (SAS1_Hs01_00122700, 00122702, 00122705, SAS1_Hs02_00332065; SigmaAldrich) and HIF2A (SAS1_Hs02_00331832, 00331833, SAS1_Hs01_00019159, SAS1_Hs01_00019157; Sigma-Aldrich). Controls included no transfection, transfection with a scrambled siRNA (Sigma-Aldrich). Based on preliminary experiments, 50 pM siRNA was chosen for all knockdown. Knockdown was analyzed using ELISA for HIF1A and HIF2A.
LongRNA library prep for next-generation sequencing. LongRNA was isolated using the miRNeasy mini kit (Qiagen). The RNA was quantified and its purity assessed with an Agilent 2100 Electrophoresis Microfluidics Analyzer. RNA was converted into an adapter-ligated cDNA library, using Ovation & Encore Library Preparation Kit (NuGen), according to the manufacture's protocol. Each cDNA sample was bar-coded, and the resulting 12 libraries (three replicate libraries for each of the four O 2 conditions) were combined for next-generation sequencing. Paired-end sequencing was performed for 50 cycles using the Illumina HiSeq-2500 sequencer.
Data alignment and mapping. RNA sequencing data was first processed with demultiplexing software (Casava 1.8.2, Illumina , San Diego, CA, USA). It was then aligned to the human genome build HG19, and to the ribosomal sequences 18 s and 28 s, using bioinformatics tool Novoalign (Novocraft, 2010). Novoalign determined unique alignments that were used to generate 1000 reads per coding segment per sample. The reads thus generated were converted into bed.files and imported to the Genomatix mapping station (Genomatix Software GmbH). The Genomatix (Ann Arbor, MI, USA) mapping station, using RNA-seq analysis, generated data in the form of Reads Per Kilobase of exon per Million fragments mapped (RPKM) for 25 000 genes in the database.
Promoter extraction. The Genomatix Genome Analyzer (GGA) MatInspector program 59 was used to extract the promoter regions for the differentially regulated genes.
Statistics. All statistics were performed with GraphPad (La Jolla, CA, USA) Prism 6 software. One-way ANOVA with Student-Newman-Keuls post hoc comparisons was used to identify changes between controls and treatments. Two-way ANOVA was used for experiments with multiple groups. Significance was defined as Po0.05; all experiments were done three times (n = 3) using triplicate sampling, and data are expressed as mean ± S.D.
Data and materials availability. Sequencing data are available from Dryad Digital Repository at http://dx.doi.org/10.5061/dryad.4b7q9.
